Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Lilly Announces CYRAMZA® (ramucirumab) Phase 3 REACH-2 Study in Second-Line Hepatocellular Carcinoma Patients Met Overall Survival Endpoint
Lilly Announces CYRAMZA® (ramucirumab) Phase 3 REACH-2 Study in Second-Line Hepatocellular Carcinoma Patients Met Overall Survival Endpoint
NDIANAPOLIS, April 4, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE.
Low dopamine may indicate early Alzheimer's
Low dopamine may indicate early Alzheimer's
A new study reports a newly discovered link between the loss of dopamine-firing cells in the brain and the brain's ability to form new memories.
Compugen, AstraZeneca unit in cancer drug development deal
Compugen, AstraZeneca unit in cancer drug development deal
JERUSALEM, April 2 (Reuters) - Israeli drugmaker Compugen Ltd said it had agreed an exclusive licensing deal with a unit of AstraZeneca to develop antibody products to treat cancer, which coul...
Mylan gets FDA nod for cost-saving HIV combo
Mylan gets FDA nod for cost-saving HIV combo
The U.
FDA rejects Alkermes depression drug
FDA rejects Alkermes depression drug
Alkermes announced that it received a Refusal to File letter from the U.
Celgene Corporation Announces Departure of President and Chief Operating Officer Scott A. Smith
Celgene Corporation Announces Departure of President and Chief Operating Officer Scott A. Smith
SUMMIT, N.
High-flying biotech Loxo tempers bullish view for cancer drug
High-flying biotech Loxo tempers bullish view for cancer drug
STAMFORD, Connecticut (Reuters) - In record time, Loxo Oncology (LOXO.
Pfizer signs deal with Allogene to develop cancer cell therapy
Pfizer signs deal with Allogene to develop cancer cell therapy
(Reuters) - Pfizer Inc said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further devel...
Harvard Researchers Look to the Fetus for Better Wound Healing
Harvard Researchers Look to the Fetus for Better Wound Healing
In-utero healing has provided a new pathway for better wound recovery.
Senators launch probe into why price of cancer drug increased 1400 percent
Senators launch probe into why price of cancer drug increased 1400 percent
Three U.
A Dangerous Antibiotic-Resistant Gene Has Spread The World. We Now Know Where It Started
A Dangerous Antibiotic-Resistant Gene Has Spread The World. We Now Know Where It Started
The mcr-1 gene, which helps bacteria resist colistin – one of the few remaining antibiotic drugs of last resort that still work – has now reached hospitals all across the world.
New drug attacks cancer-causing genes
New drug attacks cancer-causing genes
Two recent papers attack two cancer-related problems using the same drug.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand